CNCK
Coincheck Group N.V.
There isn't enough reported data to score CNCK yet.
GS
The Goldman Sachs Group, Inc.
GS's fundamentals are strong: revenue grew 19% and its operating margin rose 4 points to 40%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CNCK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
CNCK's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CNCK.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
CNCK PE Valuation
CNCK has no meaningful PE right now: it lost money over the past year.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
CNCK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| Stable | |
| Limited | |
| Low |
Analysts expect CNCK's losses to grow, with revenue declining. However, they disagree widely on these estimates.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
GS has the edge over CNCK on the outlook, with more favorable earnings and revenue expectations.
CNCK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.06 | +$0.71 |
| Q1 2026 | -$0.09 | +$0.33 |
| Q4 2025 | -$0.00 | -100% |
| Q3 2025 | -$0.76 | -142% |
| Q2 2025 | -$0.77 | -145% |
| Q1 2025 | -$0.42 | -134% |
| Q4 2024 | $0.77 | +1825% |
| Q1 2022 | $16.51 | -60% |
CNCK is still losing money, but far less than before: $0.06 per share over the past year, against $0.77 at its worst in mid-2025.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over CNCK on earnings quality, reporting a profit while its opponent remains loss making.
CNCK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $716.6M | +36% |
| Q1 2026 | $750.3M | +4.5% |
| Q4 2025 | $899.2M | +17% |
| Q3 2025 | $834.3M | +89% |
| Q2 2025 | $526.4M | +12% |
| Q1 2025 | $718.2M | +13% |
| Q4 2024 | $771.6M | +108% |
| Q3 2024 | $440.9M | +88% |
CNCK has the edge over GS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.2% | -0.2 points |
| Q1 2026 | -1.2% | -1.1 points |
| Q4 2025 | 0.6% | +13 points |
| Q3 2025 | 0.7% | +0.7 points |
| Q2 2025 | -1% | -1.9 points |
| Q1 2025 | 0% | -2.4 points |
| Q4 2024 | -12% | -14 points |
| Q3 2024 | 0% | +0.3 points |
CNCK's operating margin was −1.2% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2020.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS's revenue is growing: $18.7B last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS has the edge over CNCK on profitability, with a higher operating margin.
CNCK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$9.1M | -277% |
| Q1 2026 | -$2.9M | +$9.1M |
| Q4 2025 | $12.2M | +$16.3M |
| Q3 2025 | -$8.5M | -$3.5M |
| Q2 2025 | $5.2M | +11% |
| Q1 2025 | -$12M | -204% |
| Q4 2024 | -$4.1M | -149% |
| Q3 2024 | -$4.9M | -995% |
CNCK's free cash flow was −$8M over the past year, against −$16M the year before. Free cash flow isn't a meaningful measure for financial services companies like CNCK.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS has the edge over CNCK on cash flow, with more consistent year-over-year improvement.
CNCK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +41% | +56M shares |
| 1 year | +47% | +61M shares |
| 3 years | +1803% | +182M shares |
| 5 years | +9519% | +190M shares |
CNCK has 192M diluted shares, up 47% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over CNCK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
CNCK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 85.4x | High |
| Q1 2026 | -66.8x | Net Cash |
| Q3 2024 | 0.0x | Very low |
| Q2 2024 | -2.5x | Net Cash |
| Q1 2024 | 9.9x | High |
| Q4 2023 | -2,695.0x | Net Cash |
| Q4 2022 | 0.0x | Very low |
| Q3 2022 | -5.3x | Net Cash |
CNCK's net debt is more than 20 years of its operating earnings (EBITDA), up from 9.9 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CNCK.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over CNCK on leverage, with a lower net debt burden relative to earnings.
CNCK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.0 | Neutral |
| Stochastic | 2.8 | Oversold |
CNCK's weekly RSI is 32 (neutral) and its Stochastic is 3 (oversold).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
CNCK PE vs Financial Services Sector
CNCK has no meaningful PE right now: it lost money over the past year.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
CNCK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 17% below |
| 20 week MA | $1.85 | 41% below |
| 50 week MA | $2.17 | 49% below |
| 100 week MA | $4.03 | 73% below |
GS has stronger trend alignment. CNCK is above 0 of 4 weekly averages versus GS above 3 of 5.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
CNCK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $13.9 | $8.50 | -39% |
| 2025 | $8.50 | $3.48 | -59% |
| 2026 YTD | $3.48 | $1.10 | -68% |
CNCK has finished every year since 2024 lower, and it's down 68% so far in 2026.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has the edge over CNCK on returns for 2026, with the stronger performance.